[go: up one dir, main page]

WO2006005585A3 - Secreted polypeptide species differentially expressed during pregnancy - Google Patents

Secreted polypeptide species differentially expressed during pregnancy Download PDF

Info

Publication number
WO2006005585A3
WO2006005585A3 PCT/EP2005/007563 EP2005007563W WO2006005585A3 WO 2006005585 A3 WO2006005585 A3 WO 2006005585A3 EP 2005007563 W EP2005007563 W EP 2005007563W WO 2006005585 A3 WO2006005585 A3 WO 2006005585A3
Authority
WO
WIPO (PCT)
Prior art keywords
differentially expressed
during pregnancy
expressed during
secreted polypeptide
polypeptide species
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2005/007563
Other languages
French (fr)
Other versions
WO2006005585A2 (en
Inventor
Lydie Bougueleret
Isabelle Cusin
Eve Mahe
Anne Niknejad
Samia Reffas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Geneprot Inc
Original Assignee
Geneprot Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geneprot Inc filed Critical Geneprot Inc
Publication of WO2006005585A2 publication Critical patent/WO2006005585A2/en
Publication of WO2006005585A3 publication Critical patent/WO2006005585A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention discloses secreted polypeptides involved in pregnancy. The invention also provides methods of using compositions including the polypeptides and polynucleotides encoding them in detection assays, and for drug development.
PCT/EP2005/007563 2004-07-12 2005-07-12 Secreted polypeptide species differentially expressed during pregnancy Ceased WO2006005585A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58758604P 2004-07-12 2004-07-12
US60/587,586 2004-07-12

Publications (2)

Publication Number Publication Date
WO2006005585A2 WO2006005585A2 (en) 2006-01-19
WO2006005585A3 true WO2006005585A3 (en) 2006-08-10

Family

ID=35520133

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/007563 Ceased WO2006005585A2 (en) 2004-07-12 2005-07-12 Secreted polypeptide species differentially expressed during pregnancy

Country Status (1)

Country Link
WO (1) WO2006005585A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110045495A1 (en) * 2008-01-17 2011-02-24 Yoshinori Tanaka Composition and method for diagnosis or detection of renal cancer
EP2356998A1 (en) * 2010-02-17 2011-08-17 Université de Liège A pharmaceutical composition for treatment of thrombosis-related diseases comprising a fragment of prolactin (PRL)-growth hormone (GH) - placental lactogen (PL)-family protein

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0506377A2 (en) * 1991-03-29 1992-09-30 Kenji Sobue Calmodulin binding protein
WO2002038168A2 (en) * 2000-11-07 2002-05-16 Nemod Immuntherapie Ag Use of selectin-binding active ingredients for the treatment of inflammatory and tumoral diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0506377A2 (en) * 1991-03-29 1992-09-30 Kenji Sobue Calmodulin binding protein
WO2002038168A2 (en) * 2000-11-07 2002-05-16 Nemod Immuntherapie Ag Use of selectin-binding active ingredients for the treatment of inflammatory and tumoral diseases

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HALL SUSAN M ET AL: "Origin, differentiation, and maturation of human pulmonary veins", AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, vol. 26, no. 3, March 2002 (2002-03-01), pages 333 - 340, XP002370147, ISSN: 1044-1549 *
LEIK COURTNEY E ET AL: "Isolation and culture of arterial smooth muscle cells from human placenta", HYPERTENSION (BALTIMORE), vol. 43, no. 4, April 2004 (2004-04-01), pages 837 - 840, XP002370148, ISSN: 0194-911X *
WORD R ANN ET AL: "Contractile elements and myosin light chain phosphorylation in myometrial tissue from nonpregnant and pregnant women", JOURNAL OF CLINICAL INVESTIGATION, vol. 92, no. 1, 1993, pages 29 - 37, XP008060646, ISSN: 0021-9738 *

Also Published As

Publication number Publication date
WO2006005585A2 (en) 2006-01-19

Similar Documents

Publication Publication Date Title
WO2006017538A3 (en) Hk1-binding proteins
IL200404A0 (en) 191P4D12(b) PROTEINS, POLYNUCLEOTIDES ENCODING THE SAME; ANTIBODIES BINDING THERETO AND USES THEREOF
WO2006066024A3 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
WO2006083276A3 (en) Interferon-alpha polypeptides and conjugates
WO2002002636A3 (en) Membrane associated protein zupari
WO2005113592A3 (en) Interferon-alpha polypeptides and conjugates
WO2005047459A3 (en) Sars nucleic acids, proteins, antibodies, and uses thereof
WO2004085648A3 (en) Nogo receptor binding protein
WO2005028497A3 (en) Receptor binding peptides derived from the sars s protein
WO2008060483A3 (en) Protein-protein interaction biosensors and methods of use thereof
WO2005087793A3 (en) Immunostimulatory compositions and uses thereof
WO2005015206A3 (en) Secreted polypeptide species associated with cardiovascular disorders
WO2006005583A3 (en) Secreted polypeptide species involved in multiple sclerosis
WO2005014635A3 (en) Secreted polypeptide species reduced in cardiovascular disorders
WO2004083241A3 (en) Btc-interacting proteins and use thereof
WO2006005585A3 (en) Secreted polypeptide species differentially expressed during pregnancy
WO2004055041A3 (en) Defensin-inducing peptides from fusobacterium
WO2004081027A3 (en) Neoplasm specific antibodies and uses thereof
WO2004106941A3 (en) Secreted polypeptide species associated with cardiovascular disorders
WO2006069765A3 (en) Secreted polypeptide species involved in multiple sclerosis
WO2006063028A3 (en) Immunostimulatory compositions and uses thereof
WO2005019825A3 (en) Secreted polypeptide species and use thereof
WO2006026355A3 (en) Relaxin-chimeric polypeptides and their preparation and use
WO2003087841A3 (en) An ephrin-b receptor protein involved in carcinoma
WO2004090551A3 (en) Secreted polypeptide species associated with cardiovascular disorders

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: COMMUNICATION PURSUANT TO RULE 69(1) EPC (EPO FORM 1205A) SENT 02.04.2007.

122 Ep: pct application non-entry in european phase

Ref document number: 05774331

Country of ref document: EP

Kind code of ref document: A2